CONTENTS:
- Attitudes toward the use of medical cannabis and the perceived efficacy, side-effects and risks: A survey of patients, nurses and physicians. HaGani N., Sznitman S., Dor M., Bar-Sela G., Oren D., Margolis-Dorfman L., et al., p. 393-402.
- Harm reduction strategies among university students who use alcohol and cannabis, and related psychological variables: A systematic review. Gonzalez-Ponce B.M., Rojas-Tejada A.J., Carmona-Marquez J., Lozano-Rojas O.M., Diaz-Batanero C., Fernandez-Calderon F., p. 403-418.
- Using decision trees to identify salient predictors of cannabis-related outcomes. Schwebel F.J., Richards D.K., Pfund R.A., Joseph V.W., Pearson M.R., p. 419-428.
- Associations of lifetime nonmedical opioid, methamphetamine, and kratom use within a nationally representative US sample. Smith K.E., Rogers J.M., Strickland J.C., p. 429-439.
- Demographic and clinical correlates of treatment completion among older adults with heroin and prescription opioid use disorders. Choi N.G., DiNitto D.M., Marti C.N., Choi B.Y., p. 440-451.
- Borderline personality disorder as a predictor of drug use variety: Cognitive vs. affective mechanisms. Wojciechowski T., p. 452-461.
- Exploring the credibility of psilocybin-assisted therapy and cognitive-behavioral therapy for depression. Altman B.R., Earleywine M., De Leo J., p. 462-470.
- Comparison of mortality rates between Italian and foreign-born patients with alcohol use disorders. Pavarin R.M., Fioritti A., Fabbri C., Sanchini S., De Ronchi D., p. 471-481.
- Development and validation of an Arabic version of the Drug Abuse Screening Test-10 (DAST-10) among Saudi drug abusers. Murad H.A.S., AlHarthi N.A., Bakarman M.A., Gazzaz Z.J., p. 482-489.